Organoidsciences Ltd. (KOSDAQ:476040)
South Korea · Delayed Price · Currency is KRW 31,700
-500 (-1.55%)
At close: Aug 27, 2025
Organoidsciences Company Description
Organoidsciences Ltd. develops regenerative therapies in South Korea.
It develops ATORM, an adult tissue derived organoid based regenerative medicine platform for the treatment of intractable intestinal ulcers, as well as salivary glands, liver, and uterus disease areas; ODISEI solutions, an organoid-based discovery platform for screening evaluation and identification; and EXPANSION, an organoid-based advanced science for innovative solutions.
The company was founded in 2018 and is based in Seongnam-si, South Korea.
Organoidsciences Ltd.
| Country | South Korea |
| Founded | 2018 |
| Industry | Pharmaceutical Preparations |
| CEO | Jong-Man Yoo |
Contact Details
Address: 338 Pangyo-ro Seongnam-si, 13488 South Korea | |
| Phone | 82 2 707 2024 |
| Website | organoidrx.com |
Stock Details
| Ticker Symbol | 476040 |
| Exchange | KOSDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | KRW |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Jong-Man Yoo | Chief Executive Officer |
| Jinman Hong | Chief Financial Officer |